Nov 11, 2015 - Approximately 50% of pa ents who die from prostate cancer have metasta c ... The Prostate Cancer Registry, the first interna onal, prospec ve,.
Abstract 5024
PROSTATE CANCER REGISTRY
The Prostate Cancer Registry: Do Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Differ According to Metastatic Status at Diagnosis?
Simon Chowdhury,1 Alison J. Birtle,2 Anders Bjartell,3 Luis Costa,4,5 Susan Feyerabend,6 Luca Galli,7 Ewa Kalinka-Warzocha,8 Gero Kramer,9 Nicolaas Lumen,10 Pablo Maroto,11 Vsevolod B. Matveev,12 Thomas Paiss,13 Dominique Spaeth,14 Laurent Antoni,15 Edwin Klumper,16 Robert Wapenaar,17 and Emma Lee15 2
1
3
4
5 10
13
14
11
12
15
BACKGROUND
▶ ▶
▶
▶
▶
▶
▶
–
▶
and how it is managed.
▶
Figure 5. Analgesic Use at Study Entry (mCRPC)
▶
▶ 1
30
2
RESULTS
▶ ▶
▶
▶
▶
▶
10
Figure 3. Number of Bone Metastases at Study Entry (mCRPC)
40 35 30 25 20 15 10 5 0
0
50
CONCLUSIONS Radical
Radical
10 0
–
▶ 0
▶
OBJECTIVES M0 n = 526
▶
M1 n = 549
▶
▶
▶
▶ M0 n = 526
M1 n = 549
METHODS
Figure 4. Bone-targeted Agent Use at Study Entry (mCRPC) a
Study Design ▶
▶ ▶
REFERENCES
2
1. 2. 3.
30
n = 530
25
20.2
20 15 10
▶
▶
11.3
ACKNOWLEDGEMENTS
14.0
5 0
12-18
4.
n = 234
18.0
11.8
10
Eur Urol
0
18-24
▶ a
Poster presented at the 2016 ASCO Annual Meeting, June 3-7, 2016, Chicago, USA ♦ Supported by funding from Janssen EMEA
